Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes

NCT02749942 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.

NCT NCT02749942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RISCAID Study: Remote ISchemic Conditioning for Angiopathy In Diabetes
Lead sponsor
Steno Diabetes Center Copenhagen
Phase
Not applicable
Overall status
Completed
Start date
May 11, 2016
Completion date
July 11, 2017
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease